AAAAAA
Results:
1-7
|
Results: 7
Authors:
Keever-Taylor, CA
Bredeson, C
Loberiza, FR
Casper, JT
Lawton, C
Rizzo, D
Burns, WH
Margolis, DA
Vesole, DH
Horowitz, M
Zhang, MJ
Juckett, M
Drobyski, WR
Citation: Ca. Keever-taylor et al., Analysis of risk factors for the development of GVHD after T cell-depletedallogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion, BIOL BLOOD, 7(11), 2001, pp. 620-630
Authors:
Keever-Taylor, CA
Klein, JP
Eastwood, D
Bredeson, C
Margolis, DA
Burns, WH
Vesole, DH
Citation: Ca. Keever-taylor et al., Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factortype and role of CD34(+) cell dose, BONE MAR TR, 27(8), 2001, pp. 791-800
Authors:
Epperson, DE
Margolis, DA
McOlash, L
Janczak, T
Barrett, AJ
Citation: De. Epperson et al., In vitro T-cell receptor V beta repertoire analysis may identify which T-cell V beta families mediate graft-versus-leukaemia and graft-versus-host responses after human leucocyte antigen-matched sibling stem cell transplantation, BR J HAEM, 114(1), 2001, pp. 57-62
Authors:
Margolis, DA
Casper, JT
Segura, AD
Janczak, T
McOlash, L
Fisher, B
Miller, K
Gorski, J
Citation: Da. Margolis et al., Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire, BIOL BLOOD, 6(4), 2000, pp. 408-415
Authors:
Strasser, SI
Shulman, HM
Flowers, ME
Reddy, K
Margolis, DA
Prumbaum, M
Seropian, SE
McDonald, GB
Citation: Si. Strasser et al., Chronic graft-versus-host disease of the liver: Presentation as an acute hepatitis, HEPATOLOGY, 32(6), 2000, pp. 1265-1271
Authors:
Margolis, DA
Casper, JT
Citation: Da. Margolis et Jt. Casper, Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia, SEM HEMATOL, 37(1), 2000, pp. 43-55
Authors:
Drobyski, WR
Hessner, MJ
Klein, JP
Kabler-Babbitt, C
Vesole, DH
Margolis, DA
Keever-Taylor, CA
Citation: Wr. Drobyski et al., T-cell depletion plus salvage immunotherapy with donor leukocyte infusionsas a strategy to treat chronic-phase chronic myelogenous leukemia patientsundergoing HLA-identical sibling marrow transplantation (vol 94, pg 434, 1999), BLOOD, 95(4), 2000, pp. 1137-1137
Risultati:
1-7
|